Literature DB >> 10925696

[Prevention of arthralgia and myalgia from paclitaxel and carboplatin combination chemotherapy with Shakuyaku-kanzo-to].

H Fujiwara1, T Urabe, K Ueda, T Mizunoe, K Date, M Nakano, N Honda, T Sakashita, N Fujito.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925696

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


× No keyword cloud information.
  5 in total

1.  Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study.

Authors:  R Fernandes; S Mazzarello; A A Joy; G R Pond; J Hilton; M F K Ibrahim; C Canil; M Ong; C Stober; L Vandermeer; B Hutton; M da Costa; S Damaraju; Mark Clemons
Journal:  Support Care Cancer       Date:  2018-03-21       Impact factor: 3.603

2.  Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

Authors:  Charles L Loprinzi; Brandi N Reeves; Shaker R Dakhil; Jeff A Sloan; Sherry L Wolf; Kelli N Burger; Arif Kamal; Nguyet A Le-Lindqwister; Gamini S Soori; Anthony J Jaslowski; Paul J Novotny; Daniel H Lachance
Journal:  J Clin Oncol       Date:  2011-03-07       Impact factor: 44.544

3.  An Investigation of the Molecular Mechanisms Underlying the Analgesic Effect of Jakyak-Gamcho Decoction: A Network Pharmacology Study.

Authors:  Ho-Sung Lee; In-Hee Lee; Kyungrae Kang; Sang-In Park; Tae-Wook Kwon; Dae-Yeon Lee
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-01       Impact factor: 2.629

4.  Can medical herbs stimulate regeneration or neuroprotection and treat neuropathic pain in chemotherapy-induced peripheral neuropathy?

Authors:  Sven Schröder; Kathrin Beckmann; Giovanna Franconi; Gesa Meyer-Hamme; Thomas Friedemann; Henry Johannes Greten; Matthias Rostock; Thomas Efferth
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-31       Impact factor: 2.629

5.  Jakyakgamcho-tang in the relief of delayed-onset muscle soreness in healthy adults: study protocol for a randomized, double-blind, placebo-controlled, crossover design clinical trial.

Authors:  Kyungsun Han; Ojin Kwon; So-Young Jung; In-Hwa Park; Man-Suk Hwang; Sun-Young Park; Eui-Hyoung Hwang; Jun-Hwan Lee
Journal:  Trials       Date:  2020-02-21       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.